Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges

By Yahoo! Finance | Oct 23, 2024 at 03:04 AM EST

The CEO and CFO discuss the growth outlook for Life Sciences in 2025, emphasizing the need to assess Q4 results and factors like bioprocessing orders and China's stimulus impact. Market recovery and revenue lag are key considerations for the company's future.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.